Brown JR. Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”. haematol [Internet]. 2022Jun.1 [cited 2024Oct.20];107(6):1491-2. Available from: https://haematologica.org/article/view/haematol.2021.280310